• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    life science investing

    Apple’s ResearchKit Could Revolutionize Digital Healthcare

    Charlotte McLeod
    Mar. 10, 2015 12:29PM PST
    Life Science Investing

    CNBC reported that some market watchers believe that Apple Inc.’s (NASDAQ:AAPL) new platform for medical researchers and its Apple Watch could be a turning point for “digital, data-driven healthcare.”

    CNBC reported that some market watchers believe that Apple Inc.’s (NASDAQ:AAPL) new platform for medical researchers and its Apple Watch could be a turning point for “digital, data-driven healthcare.”

    Called ResearchKit, the new open-source platform is aimed at allowing health researchers to “enlist and monitor research subjects through Apple devices.”

    As quoted in the market news:

    Mount Sinai Hospital is one of five medical facilities that will conduct clinical trials using ResearchKit.

    Mount Sinai researchers plan to use their Asthma Mobile Health study app to recruit a large number of asthma patients, who will then use the app to track their day-to-day symptoms and habits. The hope is that the real-time tracking will help the researchers and the patients understand what triggers attacks, and document what practices can maintain better health.

    Yvonne Chan, director of personalized medicine and digital health at the Icahn School of Medicine at Mount Sinai, commented:

    This is a new era. This is really, truly revolutionizing the way clinical research could be done in the future.

    Click here to read the full CNBC report.

    personalized medicineclinical trialslife science investingapple watch
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Life Science Outlook

    Life Science Outlook

    Latest News

    Appendix 4C and Quarterly Activities Report - September 2025

    Nextech3D.ai Reports Milestone YTD Revenue Growth for AI Matchmaking in 2025 with a 95% Gross Margin

    Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    Defence Therapeutics Class A

    DTC:CC

    Cloud DX

    CDX:CA

    BioHarvest Sciences

    BHSC:CNX

    Billy Goat Brands

    GOAT:CC

    Contakt World

    HELP:CNX
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES